Laboratory Investigation

Kidney International (1991) 39, 930–937; doi:10.1038/ki.1991.116

Effects of dietary fatty acids in an animal model of focal glomerulosclerosis

David C Wheeler1, Devaki R Nair1, Jahmwant W Persaud1, Jamie Y Jeremy1, Margaret E Chappell1, Zachariah Varghese1 and John F Moorhead1

1Departments of Nephrology, Chemical Pathology and Histopathology, Royal Free Hospital, Pond Street, Hampstead, London, England, United Kingdom

Correspondence: Dr David C Wheeler, Institute of Nephrology, University of Wales College of Medicine, Cardiff Royal Infirmary, Cardiff, CF1 1SZ, Wales, United Kingdom.

Received 20 February 1990; Revised 11 October 1990; Accepted 20 December 1990.

Top

Abstract

Effects of dietary fatty acids in an animal model of focal glomerulosclerosis. The obese Zucker rat develops hyperlipidemia, proteinuria and focal glomerulosclerosis without prior changes in renal hemodynamics. To study the effects of oral fatty acid intake on the development of renal injury in this model, rats were fed standard chow or chow supplemented with either 14% fish oil or 14% beef tallow after unilateral nephrectomy at the age of 10 weeks. At 32 weeks post-nephrectomy animals were sacrificed and renal tissue saved to assess histology and glomerular eicosanoid production Fish-oil treated rats had lower mean plasma cholesterol levels and developed less proteinuria than control or tallow-fed animals although there was no difference in plasma creatinine or blood pressure. Histological analysis showed significantly fewer sclerosed glomeruli in the fish oil group (4.0 plusminus 0.8% vs. control 19.4 plusminus 4.1%, P < 0.0005 and vs. beef tallow 10.8 plusminus 1.9%, P < 0.005). Glomeruli derived from rats on fish oil supplements produced smaller amounts of prostaglandin (PG)E2 and of the stable metabolites of PGI2 (6-oxo-PGF1alpha), PGF2 (PGF2alpha and thromboxane (TX)A2 (TXB2) than those from tallow-fed animals. This study demonstrates that oral fatty acid intake may influence the development of glomerulosclerosis. The apparent beneficial effects of fish oil have not been fully defined, but may relate to favorable changes in plasma lipid concentration and renal eicosanoid production.

Top

References

  1. Brenner BM: Nephron adaptation to renal injury or ablation. Am J Physiol 249:F324–F337, 1985 | PubMed | ISI | ChemPort |
  2. Klahr S, Schreiner G, Ichikawa I: The progression of renal disease. N Engl J Med 318:1657–1666, 1988 | PubMed | ISI | ChemPort |
  3. Hostetter TH, Olson JL, Rennke HG, Venkatachalam MA, Brenner BM: Hyperfiltration in remnant nephrons: A potentially adverse response to renal ablation. Am J Physiol 241:F85–F93, 1981 | PubMed | ISI | ChemPort |
  4. Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, Klahr S: Inhibition by anticoagulant drugs of the progressive hypertension and uraemia associated with renal infarction in rats. Thromb Res 26:227–240, 1982
  5. Purkerson ML, Joist JH, Yates J, Valdes A, Morrison A, Klahr S: Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci USA 82:193–197, 1985 | PubMed | ChemPort |
  6. Moorhead JF, Chan MK, El-Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet ii:1309–1311, 1982
  7. Bray GA: The Zucker-fatty rat: A review. Fed Proc 36:148–153, 1977 | PubMed | ISI | ChemPort |
  8. Kasiske BL, Cleary MP, O'Donnell MP, Keane WF: Effects of genetic obesity on renal structure and function in the Zucker rat. J Lab Clin Med 106:598–604, 1985 | PubMed | ISI | ChemPort |
  9. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF, Phillips F: Effects of reduced renal mass on tissue lipids and renal injury in hyperlipidemic rats. Kidney Int 35:40–47, 1989 | PubMed | ISI | ChemPort |
  10. O'Donnell MP, Kasiske BL, Cleary MP, Keane WF: Effects of genetic obesity on renal structure and function in the Zucker rat. II. Micropuncture studies. J Lab Clin Med 106:605–610, 1985 | PubMed | ChemPort |
  11. Leaf A, Weber PC: Cardiovascular effects of omega-3 fatty acids. N Engl J Med 318:549–557, 1988 | PubMed | ChemPort |
  12. Kelley VE, Ferretti A, Izui S, Strom TB: A fish oil diet rich in eicosapentaenoic acid reduces cyclooxygenase metabolites and suppresses lupus in MRL-lpr mice. J Immunol 134:1914–1919, 1985
  13. Rylance PB, Gordge MP, Saynor R, Parsons V, Weston MJ: Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients. Nephron 43:196–202, 1986
  14. Simpson LO: Renal disease, polyunsaturated fatty acids and blood rheology. Nephron 44:256–258, 1986
  15. Striker GE, Killen PD, Farin FM: Human glomerular cells in vitro: Isolation and characterization. Transplant Proc 12 (suppl l):88–99, 1980 | PubMed | ISI | ChemPort |
  16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193:265–275, 1951 | PubMed | ISI | ChemPort |
  17. Jeremy JY, Mikhailidis DP, Dandona P: Adrenergic modulation of vascular prostacyclin (PGI2) secretion. Eur J Pharmacol 114:33–40, 1985
  18. Diamond JR, Karnovsky MJ: Focal and segmental glomerulosclerosis: Analogies to atherosclerosis. Kidney Int 33:917–924, 1988 | PubMed | ISI | ChemPort |
  19. Schlondorff D: The glomerular mesangial cell: An expanded role for a specialized pericyte. FASEB J 1:272–281, 1987 | PubMed | ISI | ChemPort |
  20. Grond J, van Goor H, Erkelens DW, Elema JD: Glomerular sclerotic lesions in the rat. Histochemical analysis of their macro-molecular and cellular composition. Virchows Arch [Cell Pathol] 51:521–534, 1986
  21. Lipid Research Clinics Program: The Lipids Research Clinics coronary primary prevention trial results. 1. Reduction in the incidence of coronary heart disease. JAMA 251:351–364, 1984
  22. Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP, Cashin-Hemphill L: Beneficial effects of combined colestipol-Niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257:3233–3240, 1987 | Article | PubMed | ISI | ChemPort |
  23. Keane WF, Kasiske BL, O'Donnell MP: Lipids and progressive glomerulosclerosis. A model analogous to atherosclerosis. Am J Nephrol 8:261–271, 1988 | PubMed | ISI | ChemPort |
  24. Steering Committee of the Physicians Health Study Research Group. Final report on the aspirin component of the ongoing physicians health study. N Engl J Med 321:129–135, 1989
  25. Kromann N, Green A: Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950–1974. Acta Med Scand 208:401–406, 1980 | PubMed | ChemPort |
  26. Bang HO, Dyerberg J, Nielsen AB: Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet i:1143–1146, 1971
  27. Dyerberg J, Bang HO: Haemostatic function and platelet polyunsaturated fatty acids in Eskimos. Lancet ii:433–435, 1979 | Article |
  28. Fischer S, Weber PC, Dyerberg J: The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos. Prostaglandins 32:235–241, 1986
  29. Lee TH, Hoover RL, Williams JD, Sperling RI, Ravalese J, Spur BW, Robinson DR, Corey EJ, Lewis RA, Austen KF: Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 312:1217–1224, 1985 | PubMed | ISI | ChemPort |
  30. von Schacky C: Prophylaxis of atherosclerosis with marine omega-3 fatty acids. A comprehensive strategy. Ann Intern Med 107:890–899, 1987 | PubMed | ChemPort |
  31. Prickett JD, Robinson DR, Steinberg AD: Dietary enrichment with the polyunsaturated fatty acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZBtimesNZW F1 mice. J Clin Invest 68:556–559, 1981
  32. Ito Y, Barcelli U, Yamashita W, Weiss M, Glas-Greenwalt P, Pollak VE: Fish oil has beneficial effects on lipids and renal disease of nephrotic rats. Metabolism 37:352–357, 1988
  33. Kher V, Barcelli U, Weiss M, Gallon L, Pajel P, Laskarzewski P, Pollak VE: Protective effect of polyunsaturated fatty acid supplementation in apoferritin induced murine glomerulonephritis. Prost Leuk Med 22:323–334, 1986
  34. Scharschmidt LA, Gibbons NB, McGarry L, Berger P, Axelrod M, Janis R, Ko YH: Effects of dietary fish oil on renal insufficiency in rats with subtotal nephrectomy. Kidney Int 32:700–709, 1987
  35. Barcelli UO, Miyata J, Ito Y, Gallon L, Laskarzewski P, Weiss M, Hitzemann R, Pollak VE: Beneficial effects of polyunsaturated fatty acids in partially nephrectomized rats. Prostaglandins 32:211–219, 1986 | PubMed |
  36. Ito Y, Barcelli U, Yamashita W, Weiss M, Deddens J, Pollak VE: A low protein-high linoleate diet increases glomerular PGE2 and protects renal function in rats with reduced renal mass. Prost Leuk Med 28:277–284, 1987
  37. Düsing R, Struck A, Scherf H, Pietsch R, Kramer HJ: Dietary fish oil supplements: Effects on renal hemodynamic and renal excretory function in healthy volunteers. (abstract) Kidney Int 31:268, 1987
  38. Schaap GH, Bilo HJG, Popp-Snijders C, Oe PL, Mulder C, Donker AJM: Effects of protein intake variation and omega-3 polyunsaturated fatty acids on renal function in chronic renal disease. Life Sci 41:2759–2765, 1987
  39. Hamazaki T, Tateno S, Shishido H: Eicosapentaenoic acid and IgA nephropathy. Lancet i:1017–1018, 1984
  40. Bennett WM, Walker RG, Kincaid-Smith P: Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial. Clin Nephrol 31:128–131, 1989 | PubMed | ISI | ChemPort |
  41. Leaker B, Quist R, Salehi N, Kincaid-Smith P: The effect of eicosapentanoic acid on active lupus nephritis. (abstract) Kidney Int 30:629, 1986
  42. Sweny P, Wheeler DC, Lui SF, Amin NS, Barradas MA, Jeremy JY, Mikhailidis DP, Varghese Z, Fernando ON, Moorhead JF: Dietary fish oil supplements preserve renal function in renal transplant recipients with chronic vascular rejection. Nephrol Dial Transplant 4:1071–1075, 1989
  43. Moorhead JF, Wheeler DC, Varghese Z: Glomerular structures and lipids in progressive renal disease. Am J Med 87:(5N)20N, 1989
  44. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF: Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney Int 33:667–672, 1988 | PubMed | ISI | ChemPort |
  45. Raine AEG: Hypertension, blood viscosity, and cardiovascular morbidity in renal failure: Implications of erythropoietin therapy. Lancet i:97–100, 1988

Extra navigation

.
ADVERTISEMENT